Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Mesh.i » - entrée « Proportional Hazards Models »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Propionates < Proportional Hazards Models < Proprotein Convertase 9  Facettes :

List of bibliographic references indexed by Proportional Hazards Models

Number of relevant bibliographic references: 24.
[0-20] [0 - 20][0 - 24][20-23][20-40]
Ident.Authors (with country if any)Title
000521 (2020) Jon T. Giles [États-Unis] ; Naveed Sattar [Royaume-Uni] ; Sherine Gabriel [États-Unis] ; Paul M. Ridker [États-Unis] ; Steffen Gay [Suisse] ; Charles Warne [Royaume-Uni] ; David Musselman [États-Unis] ; Laura Brockwell [Royaume-Uni] ; Emma Shittu [Royaume-Uni] ; Micki Klearman [États-Unis] ; Thomas R. Fleming [États-Unis]Cardiovascular Safety of Tocilizumab Versus Etanercept in Rheumatoid Arthritis: A Randomized Controlled Trial.
000571 (2020) Seong-Kyu Kim ; Sang Gyu Kwak [Corée du Sud] ; Jung-Yoon ChoeAssociation between biologic disease modifying anti-rheumatic drugs and incident hypertension in patients with rheumatoid arthritis: Results from prospective nationwide KOBIO Registry.
000865 (2019) Natalia Cabrera [France] ; Jean-Christophe Lega [France] ; Behrouz Kassai [France] ; Carine Wouters [Belgique] ; Anuela Kondi [France] ; Elvira Cannizzaro [Suisse] ; Andreas Woerner [Suisse] ; Aurelie Chausset [France] ; Samuel Roethlisberger [Suisse] ; Cyril Jeanneret [Suisse] ; Florence Aeschlimann [Suisse] ; Salma Malik [France] ; Agnès Duquesne [France] ; Daniela Kaiser [Suisse] ; Laetitia Higel [France] ; Anne Maes [Belgique] ; Gerald Berthet [Suisse] ; Veronique Hentgen [France] ; Isabelle Kone-Paut [France] ; Alexandre Belot [France] ; Michael Hofer [Suisse]Safety of biological agents in paediatric rheumatic diseases: A real-life multicenter retrospective study using the JIRcohorte database.
001301 (2018) Lisa Baganz [Allemagne] ; Adrian Richter [Allemagne] ; Jörn Kekow [Allemagne] ; Arnold Bussmann [Allemagne] ; Andreas Krause [Allemagne] ; Carsten Stille [Allemagne] ; Joachim Listing [Allemagne] ; Angela Zink [Allemagne] ; Anja Strangfeld [Allemagne]Long-term effectiveness of tocilizumab in patients with rheumatoid arthritis, stratified by number of previous treatment failures with biologic agents: results from the German RABBIT cohort.
001414 (2018) Kosuke Ebina [Japon] ; Motomu Hashimoto [Japon] ; Wataru Yamamoto [Japon] ; Akira Ohnishi [Japon] ; Daijiro Kabata [Japon] ; Toru Hirano [Japon] ; Ryota Hara [Japon] ; Masaki Katayama [Japon] ; Shuzo Yoshida [Japon] ; Koji Nagai [Japon] ; Yonsu Son [Japon] ; Hideki Amuro [Japon] ; Kengo Akashi [Japon] ; Takanori Fujimura [Japon] ; Makoto Hirao [Japon] ; Keiichi Yamamoto [Japon] ; Ayumi Shintani [Japon] ; Atsushi Kumanogoh [Japon] ; Hideki Yoshikawa [Japon]Drug retention and discontinuation reasons between seven biologics in patients with rheumatoid arthritis -The ANSWER cohort study.
001444 (2018) Kim Lauper [Suisse] ; Dan C. Nordström [Finlande] ; Karel Pavelka [République tchèque] ; Maria Victoria Hernández [Espagne] ; Tore K. Kvien [Norvège] ; Eirik Klami Kristianslund [Norvège] ; Maria Jose Santos [Portugal] ; Žiga Rotar [Slovénie] ; Florenzo Iannone [Italie] ; Catalin Codreanu [Roumanie] ; Galina Lukina [Russie] ; Sara L. Gale [États-Unis] ; Khaled Sarsour [États-Unis] ; Yves Luder [Suisse] ; Delphine Sophie Courvoisier [Suisse] ; Cem Gabay [Suisse]Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan-European TOCERRA register collaboration.
001689 (2017) Jacques Morel [France] ; Arnaud Constantin [France] ; Gabriel Baron [France] ; Emmanuelle Dernis ; René Marc Flipo ; Stéphanie Rist ; Bernard Combe [France] ; Jacques Eric Gottenberg [France] ; Thierry Schaeverbeke ; Martin Soubrier ; Olivier Vittecoq ; Maxime Dougados [France] ; Alain Saraux ; Xavier Mariette [France] ; Philippe Ravaud [France] ; Jean Sibilia [France]Risk factors of serious infections in patients with rheumatoid arthritis treated with tocilizumab in the French Registry REGATE.
001875 (2017) Seoyoung C. Kim [États-Unis] ; Daniel H. Solomon [États-Unis] ; James R. Rogers [États-Unis] ; Sara Gale [États-Unis] ; Micki Klearman [États-Unis] ; Khaled Sarsour [États-Unis] ; Sebastian Schneeweiss [États-Unis]Cardiovascular Safety of Tocilizumab Versus Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis: A Multi-Database Cohort Study.
001974 (2016) Naonobu Sugiyama [Japon] ; Yutaka Kawahito [Japon] ; Takao Fujii [Japon] ; Tatsuya Atsumi [Japon] ; Tatsunori Murata [Japon] ; Yosuke Morishima [Japon] ; Yuri Fukuma [Japon]Treatment Patterns, Direct Cost of Biologics, and Direct Medical Costs for Rheumatoid Arthritis Patients: A Real-world Analysis of Nationwide Japanese Claims Data.
001A74 (2016) Jeffrey R. Curtis [États-Unis] ; Fenglong Xie [États-Unis] ; Huifeng Yun [États-Unis] ; Sasha Bernatsky [Canada] ; Kevin L. Winthrop [États-Unis]Real-world comparative risks of herpes virus infections in tofacitinib and biologic-treated patients with rheumatoid arthritis.
001B46 (2016) Toshihisa Kojima [Japon] ; Nobunori Takahashi ; Koji Funahashi ; Shuji Asai ; Kenya Terabe ; Atsushi Kaneko [Japon] ; Yuji Hirano [Japon] ; Masatoshi Hayashi [Japon] ; Hiroyuki Miyake [Japon] ; Takeshi Oguchi [Japon] ; Hideki Takagi [Japon] ; Yasuhide Kanayama [Japon] ; Yuichiro Yabe [Japon] ; Tsuyoshi Watanabe [Japon] ; Takayoshi Fujibayashi [Japon] ; Tomone Shioura [Japon] ; Takayasu Ito [Japon] ; Yutaka Yoshioka [Japon] ; Hisato Ishikawa [Japon] ; Nobuyuki Asai ; Toki Takemoto ; Masayo Kojima [Japon] ; Naoki IshiguroImproved safety of biologic therapy for rheumatoid arthritis over the 8-year period since implementation in Japan: long-term results from a multicenter observational cohort study.
001C27 (2016) Jie Zhang [États-Unis] ; Fenglong Xie [États-Unis] ; Huifeng Yun [États-Unis] ; Lang Chen [États-Unis] ; Paul Muntner [États-Unis] ; Emily B. Levitan [États-Unis] ; Monika M. Safford [États-Unis] ; Shia T. Kent [États-Unis] ; Mark T. Osterman [États-Unis] ; James D. Lewis [États-Unis] ; Kenneth Saag [États-Unis] ; Jasvinder A. Singh [États-Unis] ; Jeffrey R. Curtis [États-Unis]Comparative effects of biologics on cardiovascular risk among older patients with rheumatoid arthritis.
001C29 (2016) Huifeng Yun ; Fenglong Xie ; Elizabeth Delzell ; Emily B. Levitan ; Lang Chen ; James D. Lewis [États-Unis] ; Kenneth G. Saag ; Timothy Beukelman ; Kevin L. Winthrop [États-Unis] ; John W. Baddley ; Jeffrey R. CurtisComparative Risk of Hospitalized Infection Associated With Biologic Agents in Rheumatoid Arthritis Patients Enrolled in Medicare.
001C45 (2016) Fenglong Xie ; Huifeng Yun ; Sasha Bernatsky [Canada] ; Jeffrey R. Curtis [États-Unis]Brief Report: Risk of Gastrointestinal Perforation Among Rheumatoid Arthritis Patients Receiving Tofacitinib, Tocilizumab, or Other Biologic Treatments.
001F18 (2015) Huifeng Yun ; Fenglong Xie ; Elizabeth Delzell ; Lang Chen ; Emily B. Levitan ; James D. Lewis ; Kenneth G. Saag ; Timothy Beukelman ; Kevin Winthrop ; John W. Baddley ; Jeffrey R. CurtisRisks of herpes zoster in patients with rheumatoid arthritis according to biologic disease-modifying therapy.
001F22 (2015) Ziga Rotar [Slovénie] ; Alojzija Ho Evar [Slovénie] ; Anamarija Rebolj Kodre [Slovénie] ; Sonja Praprotnik [Slovénie] ; Matija Tomši [Slovénie]Retention of the second-line biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis failing one tumor necrosis factor alpha inhibitor: data from the BioRx.si registry.
002004 (2015) Jie Zhang ; Fenglong Xie ; Elizabeth Delzell ; Huifeng Yun ; James D. Lewis ; Kevin Haynes ; Lang Chen ; Timothy Beukelman ; Kenneth G. Saag ; Jeffrey R. CurtisImpact of biologic agents with and without concomitant methotrexate and at reduced doses in older rheumatoid arthritis patients.
002038 (2015) Arsene Mekinian ; Cloé Comarmond ; Mathieu Resche-Rigon ; Tristan Mirault ; Jean Emmanuel Kahn ; Marc Lambert ; Jean Sibilia ; Antoine Néel ; Pascal Cohen ; Miguel Hie ; Sabine Berthier ; Isabelle Marie ; Christian Lavigne ; Marie Anne Vandenhende ; Géraldine Muller ; Zahir Amoura ; Hervé Devilliers ; Sébastien Abad ; Mohamed Hamidou ; Loïc Guillevin ; Robin Dhote ; Bertrand Godeau ; Emmanuel Messas ; Patrice Cacoub ; Olivier Fain ; David SaadounEfficacy of Biological-Targeted Treatments in Takayasu Arteritis: Multicenter, Retrospective Study of 49 Patients.
002126 (2015) Vijay U. Rao [États-Unis] ; Andrey Pavlov ; Micki Klearman ; David Musselman ; Jon T. Giles ; Joan M. Bathon ; Naveed Sattar ; Janet S. LeeAn evaluation of risk factors for major adverse cardiovascular events during tocilizumab therapy.
002384 (2014) Jose Ramon Maneiro [Espagne] ; Eva Perez-Pampin ; Eva Salgado ; Loreto Carmona ; Juan J. Gomez-ReinoObservational study of optimization of biologic therapies in rheumatoid arthritis: a single-centre experience.
002718 (2013) Y. Hishitani [Japon] ; A. Ogata ; Y. Shima ; T. Hirano ; K. Ebina ; Y. Kunugiza ; K. Shi ; M. Narazaki ; K. Hagihara ; T. Tomita ; H. Yoshikawa ; T. Tanaka ; A. KumanogohRetention of tocilizumab and anti-tumour necrosis factor drugs in the treatment of rheumatoid arthritis.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Proportional Hazards Models" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Proportional Hazards Models" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Proportional Hazards Models
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021